Cell
Volume 71, Issue 7, 24 December 1992, Pages 1093-1102
ArticleCostimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
References (52)
- et al.
Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
Cell
(1990) - et al.
Chimeric L6 anti-tumor antibody: genomic constrution, expression, and characterization of the antigen binding site
J. Biol. Chem.
(1992) Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells
Adv. Immunol.
(1991)- et al.
Role of the CD28 receptor in T-cell activation
Immunol. Today
(1990) - et al.
Costimulation of T cell growth
Curr. Opin. Immunol.
(1992) Tumor eradication by adoptive transfer of cytotoxic T lymphocytes
Adv. Cancer Res.
(1992)Acquisition of immunological self-tolerance
Cell
(1989)- et al.
Murine interleukin-4 displays potent anti-tumor activity in vivo
Cell
(1989) - et al.
Roles of multiple accessory molecules in T cell activation
Curr. Opin. Immunol.
(1991) - et al.
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes
J. Exp. Med.
(1992)
Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line
J. Immunol.
(1992)
Reversal of in vitro T cell clonal anergy by IL-2 stimulation
Int. Immunol.
(1992)
The foreign antigen binding site and T cell recognition regions of class I histocompatability antigens
Nature
(1987)
Toward a genetic analysis of tumor rejection antigen
Adv. Cancer Res.
(1992)
A theory of self-nonself discrimination
Science
(1970)
Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen
Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16
J. Immunol.
(1992)
Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes
J. Immunol.
(1992)
Perspectives on the role of MHC antigens in normal and malignant cell development
Adv. Cancer Res.
(1989)
Biological and experimental consequences of the zonal composition of solid tumor
Cancer Res.
(1981)
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
J. Immunol.
(1989)
Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity
Cancer Res.
(1990)
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
J. Exp. Med.
(1990)
B cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2
Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
Science
(1991)
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells
J. Virol.
(1991)
Cited by (0)
Copyright © 1992